Dear Colleagues,

Nanoparticles have been widely used for their potential applications in the field of medicine due to the various physicochemical properties that they present such as optical, electronic, magnetic properties, among others, showing great potential in medicine as in the treatment and/or diagnosis of diseases such as Alzheimer's, Parkinson's, stroke, tumors among others. Nanoparticles also allow the delivery of drugs more effectively to the area to be treated, thus allowing to reduce the necessary doses of active ingredient and thus reducing the side effects of the systemic distribution of the treatment, such as cancer therapies. When these nanoparticles are functionalized by different substances such as therapeutic agents, radionuclides, nucleic acids and antibodies, they can be used with combined therapies.

The changes of nanoparticles in the design of the structure, chemical composition and surface potentiate their properties, conferring the character of multifunctional nanoparticles and thus allowing their use by several molecular imaging techniques in a simultaneous and non-invasive way, providing morphofunctional information at different times, characterization and quantification of biological processes at the cellular and molecular level, in addition to accurate and timely diagnosis and individualized treatment of the disease. Technological innovations and the development of new smart tracers and probes have further promoted these multimodal imaging techniques, providing enhanced contrast and multidimensional functional, structural and morphological information.

Thus, nanoparticles have provided great advances in nanomedicine applied in the treatment/diagnosis of cancer, cardiovascular, infectious and neurodegenerative diseases.

Dr. Lionel Gamarra
Dr. João Paulo Borges
Dr. Luiz Cláudio Rodrigues Pereira Da Silva
Dr. Javier Bustamante Mamani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanoparticles
• nanomedicine
• therapy
• diagnosis
• theranostic
• cancer
• neurodegenerative diseases
• cardiovascular diseases
• infectious disease
• nanotoxicology